Othman Al-Sawaf, MD, University Hospital of Cologne, Cologne, Germany, describes the distinct characteristics of patients who are at a higher risk of developing Richter’s syndrome, and outlines the treatment options for these patients. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.